Gyki-52466
Gyki-52466 is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target glutamate receptor 4, glutamate receptor 1, glutamate receptor 2, and glutamate receptor 3.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
12 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | 2 | 1 | — | — | — | 3 | ||
| Parkinson disease | D010300 | EFO_0002508 | G20 | 1 | 3 | — | — | — | 3 |
| Dyskinesias | D020820 | G24 | 1 | 2 | — | — | — | 2 | |
| Glioblastoma | D005909 | EFO_0000515 | — | 2 | — | — | — | 2 | |
| Movement disorders | D009069 | EFO_0004280 | G25 | 1 | 1 | — | — | — | 1 |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | 1 | — | — | — | 1 |
| Central nervous system neoplasms | D016543 | — | 1 | — | — | — | 1 | ||
| Astrocytoma | D001254 | EFO_0000271 | — | 1 | — | — | — | 1 | |
| Oligodendroglioma | D009837 | EFO_0000631 | — | 1 | — | — | — | 1 | |
| Epilepsy | D004827 | EFO_0000474 | G40.9 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | GYKI-52466 |
| INN | talampanel |
| Description | GYKI 52466 is a benzodiazepine. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC1=NN=C(c2ccc(N)cc2)c2cc3c(cc2C1)OCO3 |
Identifiers
| PDB | — |
| CAS-ID | 102771-26-6 |
| RxCUI | — |
| ChEMBL ID | CHEMBL275006 |
| ChEBI ID | 79560 |
| PubChem CID | 3538 |
| DrugBank | — |
| UNII ID | CVS43XG1L5 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
GRIA4
GRIA4
GRIA1
GRIA1
GRIA2
GRIA2
GRIA3
GRIA3
Organism
Homo sapiens
Gene name
GRIA4
Gene synonyms
GLUR4
NCBI Gene ID
Protein name
glutamate receptor 4
Protein synonyms
AMPA-selective glutamate receptor 4, GluA4, gluR-4, GluR-D, Glutamate receptor ionotropic, AMPA 4, glutamate receptor, ionotrophic, AMPA 4, glutamate receptor, ionotropic, AMPA 4
Uniprot ID
Mouse ortholog
Gria4 (14802)
glutamate receptor 4 (Q9Z2W8)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 364 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
10,042 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more